Clinical Trial

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)

Study acronym: RADIO-RYTHMIC
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the study : to compare the Recurrence-Free survival (RFS) between arms. RFS is defined as time from randomisation to the first recurrence (either local-regional or distant) or death of any cause.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2021-01-26; most recent amendment 2026-04-17.
Status change: Not Yet Recruiting → Recruiting 2022-01-06
Trial Details
NCT Number NCT04731610
Lead Sponsor Institut Curie
Conditions Thymoma Malignant Recurrent
Enrollment 314 participants
Start Date 2021-12-28
Primary Completion 2031-12-28 (estimated)
Study Completion 2032-12-28 (estimated)
Updated on ClinicalTrials.gov 2026-04-20